These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20959827)

  • 1. Socioeconomic position and participation in colorectal cancer screening.
    Frederiksen BL; Jørgensen T; Brasso K; Holten I; Osler M
    Br J Cancer; 2010 Nov; 103(10):1496-501. PubMed ID: 20959827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
    Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme.
    van de Schootbrugge-Vandermeer HJ; Lansdorp-Vogelaar I; de Jonge L; van Vuuren AJ; Dekker E; Spaander MCW; Ramakers CRB; Nagtegaal ID; van Kemenade FJ; van Leerdam ME; Toes-Zoutendijk E
    Eur J Cancer; 2023 Sep; 190():112942. PubMed ID: 37406529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program.
    Mai TTX; Lee YY; Suh M; Choi E; Lee EY; Ki M; Cho H; Park B; Jun JK; Kim Y; Oh JK; Choi KS
    Yonsei Med J; 2018 Nov; 59(9):1034-1040. PubMed ID: 30328317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
    Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
    Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide.
    de Klerk CM; Gupta S; Dekker E; Essink-Bot ML;
    Gut; 2018 Apr; 67(4):679-687. PubMed ID: 28073892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic predictors of participation in colorectal cancer screening.
    Deding U; Henig AS; Salling A; Torp-Pedersen C; Bøggild H
    Int J Colorectal Dis; 2017 Aug; 32(8):1117-1124. PubMed ID: 28501944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal occult blood test screening uptake among immigrants from Muslim majority countries: A retrospective cohort study in Ontario, Canada.
    Vahabi M; Lofters A; Wong JP; Ellison L; Graves E; Damba C; Glazier RH
    Cancer Med; 2019 Nov; 8(16):7108-7122. PubMed ID: 31568705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.
    von Wagner C; Baio G; Raine R; Snowball J; Morris S; Atkin W; Obichere A; Handley G; Logan RF; Rainbow S; Smith S; Halloran S; Wardle J
    Int J Epidemiol; 2011 Jun; 40(3):712-8. PubMed ID: 21330344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
    Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
    Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study.
    Pallesen AVJ; Herrstedt J; Westendorp RGJ; Mortensen LH; Kristiansen M
    Acta Oncol; 2021 Mar; 60(3):323-332. PubMed ID: 33427545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing participation in colorectal cancer screening-a qualitative study in an ethnic and socio-economically diverse inner city population.
    Dharni N; Armstrong D; Chung-Faye G; Wright AJ
    Health Expect; 2017 Aug; 20(4):608-617. PubMed ID: 27550367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening knowledge, attitudes and behavioural intention among Indigenous Western Australians.
    Christou A; Thompson SC
    BMC Public Health; 2012 Jul; 12():528. PubMed ID: 22809457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.
    Bjerrum A; Milter MC; Andersen O; Fischer A; Lynge E
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1433-7. PubMed ID: 26352132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.